Immunosuppressive therapy for hypoplastic myelodysplastic syndrome

Cancer

Volumn 79, Issue 8, 1997, Pages 1548-1551

  Biesma, Douwe H ^a,b   Van Den Tweel, Jan G ^a   Verdonck, Leo F ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

antithymocyte globulin; cyclospori n A; dysplasia; hypocellularity; hypoplastic myelodysplastic syndrome; immunosuppressants; pancytopenia

Indexed keywords

CYCLOSPORIN A; LYMPHOCYTE ANTIGEN; THYMOCYTE ANTIBODY;

ARTICLE; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; CASE REPORT; DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPLASIA; IMMUNOSUPPRESSIVE TREATMENT; MALE; MYELODYSPLASIA; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTILYMPHOCYTE SERUM; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PREDNISONE;

EID: 0030992129     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970415)79:8<1548::AID-CNCR16>3.0.CO;2-Y     Document Type: Article

References (13)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, et al. The French-American-British (FAB) Cooperative Group. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982;51:189-99.
2. Greenberg PL. The smoldering myeloid leukemic states: clinical and biological features. Blood 1983;61:1035-44.
3. Nand S, Godwin JE. Hypoplastic myelodysplastic syndrome. Cancer 1988;62:958-64.
4. Miescher PA, Favre H, Beris P. Autoimmune myelodysplasias. Semin Hematol 1991;28:322-30.
5. Mineishi S, Filippa D, Childs B, Castro-Malaspina H. Hypoplastic myelodysplastic syndrome (MDS): clinical, hematologie, and pathologic observations in 36 cases [abstract]. Blood 1994;84:315a.
6. Fohlmeister I, Fischer R, Mödder B, Rister M, Schaefer HE. Aplastic anaemia and the hypocellular myelodysplastic syndrome: histomorphological, diagnostic, and prognostic features. J Clin Pathol 1985;38:1218-24.
7. Tuzuner N, Cox C, Rowe JM, Watrous D, Bennett JM. Hypocellular myelodysplastic syndromes (MDS): new proposals. Br J Haematol 1995;91:612-7.
8. Speck B. Allogeneic bone marrow transplantation for severe aplastic anemia. Semin Hematol 1991;28:318-20.
9. Gluckman E, Devergie A, Poros A, Degoulet P. Results of immunosuppression in 170 cases of severe aplastic anaemia. Br J Haematol 1982;51:541-50.
10. Green AR, Shuttleworth D, Bowen DT, Bentley DP. Cutaneous vasculitis in patients with myelodysplasia. Br J Haematol 1990;74:364-5.
11. Mufti GJ, Figes A, Hamblin TJ, Oscier DG, Copplestone JA. Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies. Br J Haematol 1986;63:143-7.
12. Enright H, Jacob HS, Vercellotti G, Howe R, Belzer M, Miller W. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol 1995;91:403-8.
13. List AF, Glinsmann-Gibson B, Spier C, Taetle R. In vitro and in vivo response to cyclosporin-A in myelodysplastic syndromes (MDS): identification of a hypocellular subset responsive to immune suppression [abstract]. Blood 1992; 80:28a.